Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Mu opioid receptor phosphorylation, desensitization, and ligand efficacy.

Yu Y, Zhang L, Yin X, Sun H, Uhl GR, Wang JB.

J Biol Chem. 1997 Nov 14;272(46):28869-74.

2.

Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters.

Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, Wang JB.

J Biol Chem. 1996 May 10;271(19):11449-54.

3.

Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.

Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G.

Mol Pharmacol. 2006 Aug;70(2):676-85. Epub 2006 May 8.

6.

Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.

Bailey CP, Couch D, Johnson E, Griffiths K, Kelly E, Henderson G.

J Neurosci. 2003 Nov 19;23(33):10515-20.

7.

Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization.

Koch T, Brandenburg LO, Liang Y, Schulz S, Beyer A, Schröder H, Höllt V.

J Neurochem. 2004 Feb;88(3):680-8.

8.

Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors.

Borgland SL, Connor M, Osborne PB, Furness JB, Christie MJ.

J Biol Chem. 2003 May 23;278(21):18776-84. Epub 2003 Mar 17.

10.

Agonist-induced mu opioid receptor phosphorylation and functional desensitization in rat thalamus.

Deng HB, Yu Y, Wang H, Guang W, Wang JB.

Brain Res. 2001 Apr 20;898(2):204-14.

PMID:
11306006
11.

Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors.

Wang HL, Chang WT, Hsu CY, Huang PC, Chow YW, Li AH.

Biochem Pharmacol. 2002 Jul 15;64(2):257-66.

PMID:
12123746
12.

Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.

Yoburn BC, Purohit V, Patel K, Zhang Q.

Eur J Pharmacol. 2004 Sep 13;498(1-3):87-96. Erratum in: Eur J Pharmacol. 2004 Dec 15;506(2):199.

PMID:
15363980
13.

mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control.

Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N, Comb MJ.

J Biol Chem. 1998 Sep 4;273(36):23534-41.

14.

Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor.

Chen C, Li J, Bot G, Szabo I, Rogers TJ, Liu-Chen LY.

Eur J Pharmacol. 2004 Jan 12;483(2-3):175-86.

PMID:
14729105
16.

Receptor endocytosis counteracts the development of opioid tolerance.

Koch T, Widera A, Bartzsch K, Schulz S, Brandenburg LO, Wundrack N, Beyer A, Grecksch G, Höllt V.

Mol Pharmacol. 2005 Jan;67(1):280-7. Epub 2004 Oct 8.

18.
20.

Mutagenesis of a single amino acid in the rat mu-opioid receptor discriminates ligand binding.

Bot G, Blake AD, Li S, Reisine T.

J Neurochem. 1998 Jan;70(1):358-65.

Supplemental Content

Support Center